Abbott Laboratories

0 members

What's driving coverage of Abbott Laboratories right now?

Corporate ratings

High Risk

Abbott Laboratories is rated high risk because it scored poorly across all measured categories, including cancellations, discriminatory philanthropy, employment protection, advocacy bias, funding, and political actions. The company is seen as prioritizing politically driven and identity-based initiatives over merit and core business objectives, which the report argues undermines free speech, free enterprise, and shareholder interests.

CancellationsHigh Risk
Discriminatory PhilanthropyHigh Risk
Employment ProtectionHigh Risk
Advocacy BiasHigh Risk
FundingHigh Risk
Political ActionsHigh Risk

coverage spread: L24/C35/R41

Comments

Ask this entity anything:

Free account · your comment posts right after signup

Photo: ajay_suresh / Wikimedia Commons (CC BY 2.0)
Business
Abbott Reaches $670M Settlement Over Preterm Formula Litigation
Abbott has reached a settlement with three law firms to resolve roughly 2,000 NEC-related infant claims tied to preterm formulas for about $670 million, a move that reduces litigation risk while Abbott and health authorities maintain formulas are safe. The company disclosed the settlement in an 8-K and noted ongoing lawsuits and bellwether cases across several jurisdictions as the broader fight over NEC risk in preterm formulas continues.
11 sources

Abbott Laboratories

Corporate ratings

Comments

Abbott Reaches $670M Settlement Over Preterm Formula Litigation

Abbott Laboratories

Corporate ratings

Comments

Abbott Reaches $670M Settlement Over Preterm Formula Litigation

Abbott Laboratories across IJR

Overview

Overview

Abbott Laboratories across IJR